The Medical Director of Radnet Inc (NASDAQ: RDNT) is Selling Shares

Today, the Medical Director of Radnet Inc (RDNTResearch Report), John Crues, sold shares of RDNT for $753.5K.

Following John Crues’ last RDNT Sell transaction on May 21, 2019, the stock climbed by 1.4%.

See today’s analyst top recommended stocks >>

Based on Radnet Inc’s latest earnings report for the quarter ending June 30, the company posted quarterly revenue of $289 million and quarterly net profit of $4.9 million. In comparison, last year the company earned revenue of $244 million and had a net profit of $5.41 million. The company has a one-year high of $16.54 and a one-year low of $9.97. RDNT’s market cap is $755.2M and the company has a P/E ratio of 21.02.

The insider sentiment on Radnet Inc has been negative according to 25 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.

John Crues’ trades have generated a -10.1% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

RadNet, Inc. provides freestanding, fixed-site outpatient diagnostic imaging services in the United States. Its centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders and reduce unnecessary invasive procedures.